lastests post

The FDA adds 3 new compounds to Schedule III drugs.. Details

published Official Gazette In its issue issued today, the Egyptian Medicines Authority Decision No. 697 of 2022 added each of Aminopyridine, BOC-4-IP, Norfentanil and their salts, analogues, esters, ethers and analogues to Schedule 3 of the Anti-Narcotics Law .

The Official Gazette published, in its issue issued this morning, the Drug Authority’s decision No. 55 of 2022 on adding 18 pharmaceutical groups, their derivatives, analogues, esters, ethers, salts of their analogues, esters, and preparations, wherever they are, to the second section of Table No. 1 attached to the Drug Control Law and regulating their use and trafficking in them. .

These groups included fentanyl, alpha-methylfentanyl, para-fluorofentanil, beta-hydroxyfentanyl, beta-hydroxy-3-fentanyl, 3-methylfentanyl, parafluorobutyrylfentanyl, orthofluorfentanil, methoxyacetylfentanyl, cyclopropylfentanyl, carfentanil, ocfentanil, Furanyl Fentanyl, Acryloyl Fentanyl, 4-Fluoroisobutyrate Fentanyl, Tetrahydrofuranyl Fentanyl, Crotonyl Fentanyl, Valerylfentanyl .

The Drug Authority said that the substances mentioned in Article No. 1 of their items in the second section of Table No. 1 are transferred to the group in the second section of Table No. 1, because they are considered derivatives of this group.

Newspaper
Newspaper

Official Gazette decision
Official Gazette decision

Related Articles

Back to top button